147
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Budget Cuts to the U.S. EPA Will Reduce Government Data on Pollutants, and Increase Reliance on Industry Data

Pages 244-246 | Published online: 19 Jul 2013

References

  • Committee on Science and Technol-ogy, U.S. House of Representatives. http://science.house.gov/press/prarticle.aspx?newsid=1723.
  • The Bush Administration& apos;s fiscal year (FY) 2008 budget proposal cuts pro-grams in the Environmental Protection Agency by $400 million from the FY 2007 budget, to $7.2 billion. This FY08 proposed budget represents the lowest funding request in this century in real dollars, FY 2004 being the high at $8.4 billion. It cuts almost $2.5 billion from the agency high when accounting for inflation. The FY08 EPA funding dedicated to research and develop-ment would be cut by 3.5% from the FY07 level, to $547 million. EPA FY 2008 Proposed Budget is available at http://www.epa.gov/ocfo/budget/20 08/2008cj.htm.
  • American Association for the Advance-ment of Science. AAAS Analysts See Mixed Prospects for Federal R&D Investment in 2007 and 2008. Edward W. Lempinen. February 12, 2007. www. aaas.org /news/rele ases/ 2007/ 0212budget.shtml.
  • See the ILSI website for a full list of itsmembership: http://www.ilsi.org/aboutilsi/.
  • The ILSI IRS Form 990 for 2005 lists $2.5 million in government contribu-tions. The EPA Grants Awards Database reports over $2 million in awards to the 2. ILSI Risk Science Institute. In a Janu-ary, 2007, response to a request from J. Sass under the Freedom of Informa-don Act, the EPA provided a list of the ILSI projects that EPA participates in. FOIA Request HQ-RIN-0029-07.
  • Examples of chemicals that are peroxi-some proliferator agonists include di ( 2-e thyl h exyl)-phthalate (DEHP), perfluororoctanoic acid (PFOA), tri-chloroethylene (TCE), perchloroethyl-ene, 2,4-13, and the phenoxyacetic acid herbicides.
  • Klaunig JE, Babich MA, Baetcke KP., et al PPARa agonist-induced rodent tumors: modes of action and human relevance, Grit Rev Toxicol. 2003; 33: 655–780.
  • December 9-10, 2003: Proposed OPPTS Science Policy: PPAR-alpha Mediated Hepatocarcinogenesis in Rodents and Relevance to Human Health Risk Assessments (EPA Docket Number OPP-2003-0338). Transmittal of meeting minutes of the FIERA Sci-entific Advisory Panel. Memorandum, March 5, 2004, from Steven M. Knott.
  • See DuPont fined more than $10M over Teflon, Randall Chase, Associated Press (December 14, 2005); Consent Agreement, December 14, 2005. http:www.epa.gov/compliance/resources/cases/civil/tsca/eabmemodupontpfoasettlement121405.pdf.
  • Cancer rates high in C8 areas. Resi-dents in the communities where water is polluted with the toxic chemical C8 have elevated levels of several cancers, according to a previously confidential state government analysis. Charleston Gazette, Charleston, WV. May 14, 2007. http://wvgazette.coxn/section/news/2007031320.
  • Teichman K. Acting Deputy Assistant Administrator for Science, ORD. Pow-erpoint presentation to the EPA Sci-ence Advisory Board Executive Com-mittee. February 22, 2007. http://www.epa.gov/sab/pdf/ord_teichman_sab02222007.pdf. Also EPA-SAB-07-004 Comments on EPA's Strategic Research Directions and Research Budget for FY 2008, An Advisory Report of the U.S. Environmental Pro-tection Agency Science Advisory Board. http://www.epa.gov/sab/pdf/sab-07-004.pdf.
  • Letter to Honorable Thad Cochran, Chairman, and Honorable Robert C. Byrd, Ranking Member, Senate Com-mittee on Appropriations. From E Miller, R Zdenek, D Croser, et al. Feb-ruary 14, 2006.
  • EPA Eyes Expanded Risk Database Used In Toxic Regulation, Cleanups. The managers of an EPA chemical risk database are considering adding short-term and acute exposure categories on several chemicals to gauge the resources needed to add the broader risk data to the system. January 27, 2003. Inside Washington Publishers.
  • OMB Opposes First-Time Child Cancer Factor Use In EPA Risk Assessment. “The White House Office of Manage-ment & Budget (OMB) is reportedly objecting to EPA's first-time use of a new children's cancer guideline in a draft risk assessment for ethylene oxide (E0) that seeks to significantly strengthen the safe exposure level, according to EPA sources... The draft risk assessment, released Sept. 22 of last year by the agency's National Center for Environmental Assessment, pro-poses tightening the agency's 1985 bench point of 3.6 parts per billion to 0.06 parts per trillion—a significant change that could have a host of rami-fications for industry. . . . Ethylene oxide is a common chemical that is widely manufactured, and is used as a medical sterilant as well as to make anti-freeze, detergents and polyester.” January 26, 2007. Inside Washington Publishers.
  • Congressional Research Service. Restructuring EPA's Libraries: Back-ground and Issues for Congress. RS22533. January 3, 2007.
  • http://www.peer.org/campaigns/publichealth/epa_library/index.php.
  • Letter from Dwight A. Welch et al. Pres-idents of 16 Local Unions to Conrad Burns and Byron Dorgan, United States Senate. June 29, 2006. http:www.peer.org/docs/epa/06_29_6_union_library_ltr.pdf.
  • Summary Report of the Peer Review Workshop on the Nanotechnology White Paper: External Review Draft. Washington, DC, April 19-20, 2006. Prepared by the U.S. EPA Office of the Science Advisor, by Versar, Inc. http:www.epa.gov/osa/pdfs/nanotech/nanotechnology-peer-review-workshop-summary-report-final-070706.pdf.
  • U.S. House of Representatives (http:www.house.gov/science) Science Commit-tee. Boehlert calls for better coordina-don and greater funding to understand nanotechnology risks: Administration Releases Report on “Research Needs.” September 21, 2006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.